MGH McLean Adult Psychiatry Residency Program

McLean Chief Scientific Officer and RCP senior advisor Kerry Ressler is featured along with Kay Tye in NOVA broadcast on the science and fun of fear.

Today Takeda Pharmaceutical Company Limited (TSE: 4502) and the New York Academy of Sciences (NYAS) announce the Honorees of the inaugural Innovators in Science Award for their commitment to and excellence in neuroscience research.

The Winner of the Senior Scientist Award is Shigetada Nakanishi, M.D., Ph.D., Director, Suntory Foundation for Life Sciences Bioorganic Research Institute in Japan. Nakanishi is honored for developing innovative cloning strategies for membrane embedded transmitter receptors and subsequent identification of functional genes encoding NMDA and G-protein coupled glutamate receptors.

The Winner of the Early-Career Scientist Award is Viviana Gradinaru, Ph.D., Assistant Professor of Biology and Biological Engineering at the California Institute of Technology. Gradinaru is honored for exemplary work in developing novel tools for neuroscience and using them to probe circuits underlying locomotion, reward, and sleep.

Also recognized as Award Finalists for discoveries ranging from neural mechanisms underlying cognitive function and emotional and social behaviors, the role of astrocytes at synapses in health and disease, and ion channels that enable somatosensation and pain perception are:

Senior Scientist Finalists:

Ben Barres, M.D., Ph.D., Professor of Neurobiology, Stanford University School of Medicine

David Julius, Ph.D., Professor and Chair of Physiology, UC San Francisco

Early-Career Scientist Finalists:

Michael Halassa, M.D., Ph.D., Assistant Professor of Neuroscience, New York Universitye

Kay Tye, Ph.D., Whitehead Career Development Assistant Professor of Neuroscience, Massachusetts Institute of Technologye

These individuals will be honored at the 2017 Innovators in Science Award Ceremony and Symposium on November 28-29, at the New York Academy of Sciences in New York City.

See full post at https://www.takeda.com/newsroom/newsreleases/2017/innovators-in-science-award-honorees/

Evan Macosko ('14) was named an NIH New Innovator 2017 based on his novel technique, DropSeq

Evan Macosko, M.D., Ph.D.

Broad Institute of MIT and Harvard, Massachusetts General Hospital Project Title: Slide-Seq: High-Resolution In Situ Expression Profiling for Neuropathology Grant ID: DP2-AG-058488 Evan Macosko is a principal investigator in the Stanley Center for Psychiatric Research at the Broad institute, and an Assistant Professor of Psychiatry at Harvard Medical School. His research focuses on developing and leveraging new technologies in genomics to characterize pathophysiological mechanisms in neuropsychiatric diseases. As a postdoc in Steven McCarroll’s lab at Harvard Medical School, he developed a new method, Drop-seq, for performing highly parallel gene expression analysis of single cells from complex neural tissues. He completed a psychiatry residency at MGH and McLean Hospital, and is currently an attending psychiatrist at MGH. He holds a Ph.D. in Neuroscience and Genetics from Rockefeller University, and an M.D. from Weill Cornell Medical College. https://commonfund.nih.gov/newinnovator/awardrecipients